Therapeutic potential of blocking HIV entry into cells: focus on membrane fusion inhibitors

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.8, Iss.8, 1999-08, pp. : 1157-1170

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

HIV entry and fusion inhibitors

By Chantry David

Expert Opinion on Emerging Drugs, Vol. 9, Iss. 1, 2004-05 ,pp. : 1-7

Informa Healthcare

Access to resources Recommend Favorite

Entry and fusion inhibitors of HIV

By Rusconi Stefano Bulgheroni Elisabetta Citterio Paola

Expert Opinion on Therapeutic Patents, Vol. 14, Iss. 5, 2004-05 ,pp. : 733-748

Informa Healthcare

Access to resources Recommend Favorite

C-Met Inhibitors are Potential Novel Therapeutic Agents Against Listeria monocytogenes Infection Through Blocking the Bacteria Entry into Nonphagocytic Cells

Current Topics in Medicinal Chemistry, Vol. 17, Iss. 3, 2017-01 ,pp. : 278-289

Bentham Science Publishers

Access to resources Recommend Favorite

Fusion/entry inhibitors as therapies for HIV

By Redshaw Sally Westby Mike

Expert Opinion on Emerging Drugs, Vol. 6, Iss. 2, 2001-10 ,pp. : 209-224

Informa Healthcare

Access to resources Recommend Favorite

Inhibiting HIV-1 Entry with Fusion Inhibitors

Current Medicinal Chemistry, Vol. 10, Iss. 17, 2003-09 ,pp. : 1633-1642

Bentham Science Publishers

Access to resources Recommend Favorite